End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,384 KRW | +9.75% | -33.14% | +134.97% |
2022 | StemLab Inc. announced that it has received KRW 1.5000006 billion in funding | CI |
2022 | StemLab Inc. announced that it expects to receive KRW 1.5000006 billion in funding | CI |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Stem Cell Culture Solution
100.0
%
| - | - | 438 | 100.0 % | - |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 231 | 100.0 % | 438 | 100.0 % | +89.66% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Donghoon Oh
CEO | Chief Executive Officer | 61 | - |
Jong-Seong Choi
CEO | Chief Executive Officer | 60 | - |
Seung-Kwon Yoo
PSD | President | 59 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joon Chung
BRD | Director/Board Member | 60 | - |
Jong-Seong Choi
CEO | Chief Executive Officer | 60 | - |
Donghoon Oh
CEO | Chief Executive Officer | 61 | - |
Seung-Kwon Yoo
PSD | President | 59 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,378,119 | 2,619,038 ( 25.24 %) | 595,349 ( 5.737 %) | 25.24 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+134.97% | 4.76M | |
+1.43% | 94.45B | |
-1.71% | 38.9B | |
-12.68% | 32.56B | |
-12.11% | 15.98B | |
+0.08% | 13.82B | |
-12.63% | 11.34B | |
+163.45% | 9.81B | |
-53.23% | 9.67B | |
+3.52% | 8.91B |
- Stock Market
- Equities
- A258540 Stock
- Company SL Therapeutics, Inc.